Volume 32, Issue 9 (December 2021)
Studies in Medical Sciences 2021, 32(9): 707-714 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ahmadi N, Jafari A, Ghasemnejad-Berenji M, Sadeghpour S. EVALUATION OF THE PRESCRIPTION PATTERN AND DRUG INTERACTIONS OF NON-STREOIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS REFERRED TO TALEGHANI AND IMAM KHOMEINI EDUCATIONAL PHARMACIES IN URMIA IN THE FIRST 6 MONTHS OF 2019. Studies in Medical Sciences 2021; 32 (9) :707-714
URL: http://umj.umsu.ac.ir/article-1-5650-en.html
URL: http://umj.umsu.ac.ir/article-1-5650-en.html
Cellular and Molecular Research Center, Research Institute on Cellular and Molecular Medicine, Urmia University of Medical Sciences, Urmia, Iran (Correspondence author) , abbasj63@gmail.com
Abstract: (1620 Views)
Background & Aims: The prescribing pattern of non-steroidal anti-inflammatory drugs (NSAIDs) has scarcely been studied in Iran. This study aims to evaluate the prescribing pattern of NSAIDs in the prescriptions of the patients who referred to Taleghani and Imam Khomeini educational pharmacies from March 21st to September 22nd, 2019 in order to find a way to reduce their irrational and excessive prescription as well as their serious side effects.
Materials & Methods: In this retrospective, cross-sectional study all the prescriptions containing NSAIDs from March 21st to September 22nd, 2019 in Taleghani and Imam Khomeini educational pharmacies were analyzed using the Tebyan software and the drug interactions were determined using the Lexicomp application and the data was collected.
Results: Among the overall 47652 prescriptions analyzed in both pharmacies, the most and the least prescribed drug in both pharmacies were the 30 mg/mL ketorolac ampoule and the 250 ml mephenamic acid, respectively. The greatest number of major and moderate interactions between drugs in Imam Khomeini pharmacy were both seen in prescriptions containing the 30mg/mL ketorolac ampoule with the percentages of 41.9% and 32.1%, respectively; and in Taleghani pharmacy the greatest number of both interactions were seen in prescriptions containing the 30mg/1mL ketorolac ampoule with the percentages of 75.2% and 76.6%, respectively.
Conclusion: NSAIDs are widely prescribed and a high number of drug interactions are observed in prescriptions containing these drugs. We can conclude from this study that physicians need more attention and education concerning NSAID drug interactions with each other and with other drugs.
Materials & Methods: In this retrospective, cross-sectional study all the prescriptions containing NSAIDs from March 21st to September 22nd, 2019 in Taleghani and Imam Khomeini educational pharmacies were analyzed using the Tebyan software and the drug interactions were determined using the Lexicomp application and the data was collected.
Results: Among the overall 47652 prescriptions analyzed in both pharmacies, the most and the least prescribed drug in both pharmacies were the 30 mg/mL ketorolac ampoule and the 250 ml mephenamic acid, respectively. The greatest number of major and moderate interactions between drugs in Imam Khomeini pharmacy were both seen in prescriptions containing the 30mg/mL ketorolac ampoule with the percentages of 41.9% and 32.1%, respectively; and in Taleghani pharmacy the greatest number of both interactions were seen in prescriptions containing the 30mg/1mL ketorolac ampoule with the percentages of 75.2% and 76.6%, respectively.
Conclusion: NSAIDs are widely prescribed and a high number of drug interactions are observed in prescriptions containing these drugs. We can conclude from this study that physicians need more attention and education concerning NSAID drug interactions with each other and with other drugs.
References
1. Karimi A, Haerizadeh M, Soleymani F, Haerizadeh M, Taheri F. Evaluation of medicine prescription pattern using World Health Organization prescribing indicators in Iran: A cross-sectional study. J Res Pharm Pract 2014;3(2):39. [DOI:10.4103/2279-042X.137058] [PMID] [PMCID]
2. Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag 2015;11:1061. [DOI:10.2147/TCRM.S79135] [PMID] [PMCID]
3. Bethesda M. National Institute of Diabetes and Digestive and Kidney Diseases 2009. US Renal Data System: USRDS 2009 Annual Data Report 2009. [URL]
4. Verbeeck RK. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet 1990;19(1):44-66. [DOI:10.2165/00003088-199019010-00004] [PMID]
5. Vane J, Botting R. Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol 1996;25(sup102):9-21. [DOI:10.3109/03009749609097226] [PMID]
6. Maniar KH, Jones IA, Gopalakrishna R, Vangsness Jr CT. Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage. Expert Opin Pharmacother 2018;19(2):93-102. [DOI:10.1080/14656566.2017.1414802] [PMID]
7. LiverTox N. Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. 2012. [PMID]
8. Ho KY, Gwee KA, Cheng YK, Yoon KH, Hee HT, Omar AR. Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice. J Pain Res 2018;11:1937. [DOI:10.2147/JPR.S168188] [PMID] [PMCID]
9. Asanuma M, Miyazaki I. Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease. Curr Pharm Des 2008;14(14):1428-34. [DOI:10.2174/138161208784480153] [PMID]
10. O'connor N, Dargan PI, Jones AL. Hepatocellular damage from non-steroidal anti-inflammatory drugs. Qjm 2003;96(11):787-91. [DOI:10.1093/qjmed/hcg138] [PMID]
11. Katzung BG, Masters SB, Trevor AJ. Basic Clin Pharmacol 2004. [URL]
12. Zadeh E, Gholami K, Gharanjik U. Evaluation of drug interactions of Non-steroidal Anti-inflammatory drugs (NSAIDs) in Sari insured prescriptions during 1999-2001. Razi J Med Sci 2003;10(36):489-95. [URL]
13. Namazi S, Karimzadeh I. Drug utilization evaluation of unfractionated heparin in a cardiac care unit in Iran. J Pharm Res 2011;4(5):1470-2. [DOI:10.5897/AJPP10.413]
14. Mahmud S, Rosen N. History of NSAID Use in the Treatment of Headaches Pre and Post-industrial Revolution in the United States: the Rise and Fall of Antipyrine, Salicylic Acid, and Acetanilide. Curr Pain Headache Rep 2019;23(1):6. [DOI:10.1007/s11916-019-0744-6] [PMID]
15. Christopher S, Tadlock BA, Veroneau BJ, Harnish C, Perera NKP, Knab AM, et al. Epidemiological profile of pain and non-steroid anti-inflammatory drug use in collegiate athletes in the United States. BMC Musculoskelet Disord 2020;21(1):1-9. [DOI:10.1186/s12891-020-03581-y] [PMID] [PMCID]
16. Su L, Li Y, Xu R, Luo F, Gao Q, Chen R, et al. Association of ibuprofen prescription with acute kidney injury among hospitalized children in China. JAMA network open 2021;4(3):e210775-e. [DOI:10.1001/jamanetworkopen.2021.0775] [PMID] [PMCID]
17. Gutiérrez-Noya VM, Gómez-Oliván LM, del Carmen Ramírez-Montero M, Islas-Flores H, Galar-Martínez M, Dublán-García O, et al. Ibuprofen at environmentally relevant concentrations alters embryonic development, induces teratogenesis and oxidative stress in Cyprinus carpio. Sci. Total Environ 2020;710:136327. [DOI:10.1016/j.scitotenv.2019.136327] [PMID]
18. Nicollas R, Moreddu E, Le Treut-Gay C, Mancini J, Akkari M, Mondain M, et al. Ibuprofen as risk-factor for complications of acute anterior sinusitis in children. European Eur Ann Otorhinolaryngol Head Neck Dis 2020;137(2):99-103. [DOI:10.1016/j.anorl.2019.10.004] [PMID]
19. Kim M, Lee EJ, Lim K-M. Ibuprofen increases the hepatotoxicity of ethanol through potentiating oxidative stress. Biomol Ther 2021;29(2):205. [DOI:10.4062/biomolther.2020.108] [PMID] [PMCID]
20. Ala S, Hadian R. The usage pattern of Anti-inflammatory drugs-steroidal and non-steroidal-in patients referred to 13 Aban pharmacy in Sari. J Mazand Univ Med Sci 2009;19(72):82-4. [Google Scholar]
21. Zeinali M, Tabeshpour J, Maziar SV, Taherzadeh Z, Zirak MR, Sent D, et al. Prescription pattern analysis of nonsteroidal anti-inflammatory drugs in the northeastern iranian population. J Res Pharm Pract 2017;6(4):206. [DOI:10.4103/jrpp.JRPP_17_45] [PMID] [PMCID]
22. Ebrahimzadeh M A, Gholami Kh, Gaharanjik U,Javadian S.M.Evaluation of drug interactions of Non-steroidal Anti-inflammatory drugs (NSAIDs)in Sari insured prescriptions during1999-2001. J Iran Uni Med Sci 2003; 36(1): 489-96. (Persian) [URL]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
